| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Fine-tuning cardiac insulin-like growth factor 1 receptor signaling to promote health and longevity
Authors:ID Abdellatif, Mahmoud (Author)
ID Herbst, Viktoria (Author)
ID Heberle, Alexander Martin (Author)
ID Humnig, Alina (Author)
ID Pendl, Tobias (Author)
ID Durand, Sylvère (Author)
ID Cerrato, Giulia (Author)
ID Hofer, Sebastian J (Author)
ID Islam, Moydul (Author)
ID Voglhuber, Julia (Author)
ID Sedej, Simon (Author), et al.
Files:.pdf Fine-Tuning_Cardiac_Insulin-Li-Abdellatif-2022.pdf (3,06 MB)
MD5: A3C0B7B4EA8024D9D1330C55E48435AC
 
URL https://doi.org/10.1161/CIRCULATIONAHA.122.059863
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Background: The insulin-like growth factor 1 (IGF1) pathway is a key regulator of cellular metabolism and aging. Although its inhibition promotes longevity across species, the effect of attenuated IGF1 signaling on cardiac aging remains controversial. Methods: We performed a lifelong study to assess cardiac health and lifespan in 2 cardiomyocyte-specific transgenic mouse models with enhanced versus reduced IGF1 receptor (IGF1R) signaling. Male mice with human IGF1R overexpression or dominant negative phosphoinositide 3-kinase mutation were examined at different life stages by echocardiography, invasive hemodynamics, and treadmill coupled to indirect calorimetry. In vitro assays included cardiac histology, mitochondrial respiration, ATP synthesis, autophagic flux, and targeted metabolome profiling, and immunoblots of key IGF1R downstream targets in mouse and human explanted failing and nonfailing hearts, as well. Results: Young mice with increased IGF1R signaling exhibited superior cardiac function that progressively declined with aging in an accelerated fashion compared with wild-type animals, resulting in heart failure and a reduced lifespan. In contrast, mice with low cardiac IGF1R signaling exhibited inferior cardiac function early in life, but superior cardiac performance during aging, and increased maximum lifespan, as well. Mechanistically, the late-life detrimental effects of IGF1R activation correlated with suppressed autophagic flux and impaired oxidative phosphorylation in the heart. Low IGF1R activity consistently improved myocardial bioenergetics and function of the aging heart in an autophagy-dependent manner. In humans, failing hearts, but not those with compensated hypertrophy, displayed exaggerated IGF1R expression and signaling activity. Conclusions: Our findings indicate that the relationship between IGF1R signaling and cardiac health is not linear, but rather biphasic. Hence, pharmacological inhibitors of the IGF1 pathway, albeit unsuitable for young individuals, might be worth considering in older adults.
Keywords:aging, autophagy, cardiomyopathies, insulin-like growth factor 1, mitochondria, mouse, phosphatidylinositol 3-kinases
Publication status:Published
Publication version:Version of Record
Submitted for review:03.03.2022
Article acceptance date:20.04.2022
Publication date:26.05.2022
Publisher:Lippincott Williams & Wilkins, Highwire Press
Year of publishing:2022
Number of pages:Str. 1853-1866
Numbering:Letn. 145, Št. 25
PID:20.500.12556/DKUM-84966-79ece2b6-1e1d-4d67-d898-d192e3014f39 New window
UDC:616.1
ISSN on article:1524-4539
COBISS.SI-ID:126797571 New window
DOI:10.1161/CIRCULATIONAHA.122.059863 New window
Publication date in DKUM:11.08.2023
Views:711
Downloads:98
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Circulation
Shortened title:Circulation
Publisher:Lippincott Williams & Wilkins, Highwire Press
ISSN:1524-4539
COBISS.SI-ID:24103641 New window

Document is financed by a project

Funder:FWF - Austrian Science Fund
Project number:P27637-B28

Funder:FWF - Austrian Science Fund
Project number:I3301-MINOTAUR

Funder:EC - European Commission
Funding programme:H2020
Project number:101025118
Name:Spermidine in hypertension: therapeutic potential and novel mechanisms
Acronym:SPeR-ToNE

Funder:ANR - French National Research Agency
Project number:AMMICa US23/CNRS UMS3655

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:26.05.2022

Secondary language

Language:Slovenian
Keywords:staranje, avtofagija, kardiomiopatije, inzulinu podoben rastni faktor 1, mitohondriji, miši, fosfatidilinozitol 3-kinaze


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica